TAN-67, a δ1-opioid receptor agonist, reduces infarct size via activation of G(i/o) proteins and K(ATP) channels

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 274, Issue 3 43-3, 1998, Pages

  Schultz, Jo El J ^a   Hsu, Anna K ^a   Nagase, Hiroshi ^b   Gross, Garrett J ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b TORAY INDUSTRIES INC   (Japan)

Author keywords

Glibenclamide; Ischemic preconditioning; Pertussis toxin

Indexed keywords

1,2,3,4,4A,5,12,12AALPHA OCTAHYDRO 4AALPHA (3 HYDROXYPHENYL) 2 METHYLQUINOLINO[2,3 G]ISOQUINOLINE; 7 BENZYLIDENENALTREXONE; DELTA OPIATE RECEPTOR AGONIST; DELTA OPIATE RECEPTOR ANTAGONIST; GLIBENCLAMIDE; GUANINE NUCLEOTIDE BINDING PROTEIN; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; ISOQUINOLINE DERIVATIVE; PERTUSSIS TOXIN; POTASSIUM CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG SCREENING; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE REPERFUSION; HEART PROTECTION; HEMODYNAMICS; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY;

EID: 0031919982     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.1998.274.3.h909     Document Type: Article

References (66)

1. + exchange. Basic Res. Cardiol. 91: 203-209, 1996.
2. Chen, Y., A. Mesick, J. Liu, A. Hurley, and L. Yu. Molecular cloning and functional expression of a μ opioid receptor from rat brain. Mol. Pharmacol. 44: 8-12, 1993.
3. + channel. J. Biol. Chem. 269: 7839-7842, 1994.
4. 5]-enkephalin). J. Thorac. Cardiovasc. Surg. 107: 964-967, 1994.
5. Childers, S. R. Opioid receptor-coupled second messenger systems. Life Sci. 48: 1991-2003, 1991.
6. Clarke, G. D., and G. M. Dondio. Recent advances in the development of a non-peptide δ opioid analgesic. Pharmacol. Rev. Commun. 9: 49-60, 1997.
7. Cox, B. M. Opioid receptor-G protein interactions: acute and chronic effects of opioids. In: Handbook of Experimental Pharmacology: Opioids I, edited by A. Herz. New York: Springer-Verlag, 1993, p. 145-188.
8. Donnelly, T. J., R. E. Sievers, F. L. J. Vissern, W. J. Welch, and C. L. Wolfe. Heat shock protein induction in rat hearts: a role for improved myocardial salvage after ischemia and reperfusion? Circulation 85: 769-778, 1992.
9. Ela, C., J. Barg, Z. Vogel, Y. Hasin, and Y. Eilam. Distinct components of morphine effects on cardiac myocytes are mediated by the κ and δ opioid receptors. J. Mol. Cell. Cardiol. 29: 711-720, 1997.
10. 2+-transients and intracellular pH in cultured cardiac myocytes. J. Mol. Cell. Cardiol. 26: 599-613, 1993.
11. Endoh, M., M. Maruyama, and T. Iijima. Attenuation of muscarinic cholinergic inhibition by islet-activating protein in the heart. Am. J. Physiol. 249 (Heart Circ. Physiol. 18): H309-H320, 1985.
12. Evans, C. J., D. E. Keith, Jr., H. Morrison, K. Magendzo, and R. H. Edwards. Cloning of a delta opioid receptor by functional expression. Science 258: 1952-1955, 1992.
13. Fleming, J. W., P. L. Wisler, and A. M. Watanabe. Signal transduction by G proteins in cardiac tissues. Circulation 85: 420-433, 1992.
14. Gross, G. J., and J. A. Auchampach. Blockade of the ATP-sensitive potassium channels prevents myocardial preconditioning in dogs. Circ. Res. 70: 223-233, 1992.
15. + channel. Biochem. Biophys. Res. Commun. 208: 302-308, 1995.
16. Imagawa, J.-I., G. F. Baxter, and D. M. Yellon. Genistein, a tyrosine kinase inhibitor, blocks the "second window of protection" 48 h after ischemic preconditioning in the rabbit. J. Mol. Cell. Cardiol. 29: 1885-1893, 1997.
17. + channel. J. Gen. Physiol. 99: 961-983, 1992.
18. Kamei, J., A. Saitoh, M. Ohsawa, T. Suzuki, M. Misawa, H. Nagase, and Y. Kasuya. Antinociceptive effects of the selective non-peptidic δ-opioid receptor agonist TAN-67 in diabetic mice. Eur. J. Pharmacol. 276: 131-135, 1995.
19. Kieffer, B. L., K. Befort, C. Gaveriaux-Ruff, and C. G. Hirth. The delta opioid receptor: isolation of a cDNA by expression cloning and pharmacological characterization. Proc. Natl. Acad. Sci. USA 89: 12048-12052, 1992.
20. 1 receptors by G proteins in rat ventricular myocytes. Am. J. Physiol. 259 (Heart Circ. Physiol. 28): H820-H826, 1990.
21. Klein, H. H., S. Puschmann, J. Schaper, and W. Schaper. The mechanism of the tetrazolium reaction in identifying myocardial infarction. Virchows Arch. 393: 287-297, 1981.
22. Knapp, R. J., R. Landsman, S. Waite, E. Malatynska, E. Varga, W. Haq, V. J. Hruby, W. R. Roeske, H. Nagase, and H. I. Yamamura. Properties of TAN-67, a nonpeptidic δ-opioid receptor agonist, at cloned human δ- and μ-opioid receptors. Eur. J. Pharmacol. 291: 129-134, 1995.
23. Krumins, S. A., A. I. Faden, and G. Feurestein. Opiate binding in rat hearts: modulation of binding after hemorrhagic shock. Biochem. Biophys. Res. Commun. 127: 120-128, 1985.
24. Kurachi, Y. G-protein control of cardiac potassium channels. Trends Cardiovasc. Med. 4: 64-69, 1994.
25. + channels. Prog. Neurobiol. 39: 229-246, 1992.
26. 1 receptor mediated protection of the ischemic rat heart. J. Mol. Cell. Cardiol. 25: 815-821, 1993.
27. Law, P. Y., T. M. McGinn, K. M. Campbell, L. E. Erickson, and H. H. Loh. Agonist activation of δ-opioid receptor but not μ-opioid receptor potentiates fetal calf serum or tyrosine kinase receptor-mediated cell proliferation in a cell-line-specific manner. Mol. Pharmacol. 51: 152-160, 1997.
28. Lou, L.-G., and G. Pei. Modulation of protein kinase C and cAMP-dependent protein kinase by δ-opioid. Biochem. Biophys. Res. Commun. 236: 626-629, 1997.
29. Li, Y., and R. A. Kloner. Does protein kinase C play a role in ischemic preconditioning in rat hearts? Am. J. Physiol. 268 (Heart Circ. Physiol. 37): H426-H431, 1995.
30. 1 adenosine receptors in rabbit heart. Circulation 84: 350-356, 1991.
31. Liu, Y., and J. M. Downey. Ischemic preconditioning protects against infarction in rat heart. Am. J. Physiol. 263 (Heart Circ. Physiol. 32): H1107-H1112, 1992.
32. Maulik, N., M. Watanabe, Y.-L. Zu, C.-K. Huang, G. A. Cordis, J. A. Schley, and D. K. Das. Ischemic preconditioning triggers the activation of MAP kinases and MAPKAP kinase 2 in rat hearts. FEBS Lett. 396: 233-237, 1996.
33. Mayfield, K. P., and L. G. D'Alecy. Delta-1 opioid receptor dependence of acute hypoxic adaptation. J. Pharmacol. Exp. Ther. 268: 74-77, 1994.
34. Mayfield, K. P., and L. G. D'Alecy. Delta-1 opioid agonist acutely increases hypoxic tolerance. J. Pharmacol. Exp. Ther. 268: 683-688, 1994.
35. i2. Biochem. J. 267: 391-398, 1990.
36. Minami, M., T. Toya, Y. Katao, K. Maekawa, S. Nakamura, T. Onogi, S. Kaneko, and M. Satoh. Cloning and expression of a cDNA for the rat κ-opioid receptor. FEBS Lett. 329: 291-295, 1993.
37. Nagase, H., H. Wakita, K. Kawai, T. Endoh, H. Matsuura, C. Tanaka, and Y. Takezawa. Syntheses of non-peptidic delta opioid agonists and their structure-activity relationships (Abstract). Jpn. J. Pharmacol. 64: 35P, 1994.
38. North, R. A., J. T. Williams, A. Surprenant, and M. J. Christie, μ and δ receptors belong to a family of receptors that are coupled to potassium channels. Proc. Natl. Acad. Sci. USA 84: 5487-5491, 1987.
39. Pepe, S., R.-P. Xiao, C. Hohl, R. Altschuld, and E. G. Lakatta. "Cross talk" between opioid peptide and adrenergic receptor signaling in isolated rat heart. Circulation 95: 2122-2129, 1997.
40. + exchange in ischemia-reperfusion. Basic Res. Cardiol. 91: 191-202, 1996.
41. 1-opioid receptor antagonist: 7-benzylidenenaltrexone. Eur. J. Pharmacol. 218: 195-196, 1992.
42. ATP channel in rat heart: blockade of ischemic and acetylcholine-mediated preconditioning by glibenclamide. Am. J. Physiol. 271 (Heart Circ. Physiol. 40): H23-H28, 1996.
43. Richard, V., R. Blanc, N. Kaeffer, C. Tron, and C. Thuillez. Myocardial and coronary endothelial protective effects of acetylcholine after myocardial ischaemia and reperfusion in rats: role of nitric oxide. Br. J. Pharmacol. 115: 1532-1538, 1995.
44. + exchange inhibitor reduces infarct size in pigs. Cardiovasc. Res. 30: 945-951, 1995.
45. Schultz, J. J., A. K. Hsu, and G. J. Gross. Morphine mimics the cardioprotective effect of ischemic preconditioning via a glibenclamide-sensitive mechanism in the rat heart. Circ. Res. 78: 1100-1104, 1996.
46. Schultz, J. J., A. K. Hsu, and G. J. Gross. Ischemic preconditioning is mediated by a peripheral opioid receptor mechanism in the intact rat heart. J. Mol. Cell. Cardiol. 29: 1355-1362, 1997.
47. Schultz, J. J., A. K. Hsu, and G. J. Gross. Ischemic preconditioning and morphine-induced cardioprotection involve the delta (δ)-opioid receptor in the intact rat heart. J. Mol. Cell. Cardiol. 29: 2187-2195, 1997.
48. 1), but not mu (μ) or kappa (κ) opioid receptors (Abstract). J. Mol. Cell. Cardiol. 29: A200, 1997.
49. ATP channel antagonist, 5-hydroxydecanoate, blocks ischemic preconditioning in the rat heart. J. Mol. Cell. Cardiol. 29: 1055-1060, 1997.
50. Schultz, J. J., E. Rose, Z. Yao, and G. J. Gross. Evidence for involvement of opioid receptors in ischemic preconditioning in rat hearts. Am. J. Physiol. 268 (Heart Circ. Physiol. 37): H2157-H2161, 1995.
51. Schultz, J. J., Z. Yao, I. Cavero, and G. J. Gross. Glibenclamide abolishes ischemic preconditioning in a time-dependent manner in the rat heart. Am. J. Physiol. 272 (Heart Circ. Physiol. 41): H2607-H2615, 1997.
52. 1 opioid receptor antagonist in the mouse spinal cord. Life Sci. 52: 769-775, 1993.
53. Speechly-Dick, M. E., M. M. Mocanu, and D. M. Yellon. Protein kinase C: its role in ischemic preconditioning in the rat. Circ. Res. 75: 586-590, 1994.
54. Thornton, J. D., G. S. Liu, and J. M. Downey. Pretreatment with pertussis toxin blocks the protective effects of preconditioning: evidence for G-protein mechanism. J. Mol. Cell. Cardiol. 25: 311-320, 1993.
55. Ventura, C., L. Bastagli, P. Bernardi, C. M. Caldarera, and C. Guarnieri. Opioid receptors in rat cardiac sarcolemma: effect of phenylephrine and isoproterenol. Biochim. Biophys. Acta 987: 69-74, 1989.
56. 2+ release from an intracellular pool in myocytes and neurons. Circ. Res. 70: 66-81, 1992.
57. Wild, K. D., T. Vanderah, H. I. Mosberg, and F. Porreca. Opioid δ receptor subtypes are associated with different potassium channels. Eur. J. Pharmacol. 193: 135-136, 1991.
58. Williams, J. T., T. M. Egan, and R. A. North. Enkephalin opens potassium channels on mammalian central neurons. Nature 299: 74-77, 1982.
59. Wittert, G., P. Hope, and D. Pyle. Tissue distribution of opioid receptor gene expression in the rat. Biochem. Biophys. Res. Commun. 218: 877-881, 1996.
60. Xiao, R.-P., S. Pepe, H. A. Spurgeon, M. C. Capogrossi, and E. G. Lakatta. Opioid peptide receptor stimulation reverses β-adrenergic effects in rat heart cells. Am. J. Physiol. 272 (Heart Circ. Physiol. 41): H797-H805, 1997.
61. Yao, Z., and G. J. Gross. Acetylcholine mimics ischemic preconditioning via a glibenclamide-sensitive mechanism in dogs. Am. J. Physiol. 264 (Heart Circ. Physiol. 33): H2221-H2225, 1993.
62. Yao, Z., and G. J. Gross. Role of nitric oxide, muscarinic receptors, and the ATP-sensitive potassium channel in mediating the effects of acetylcholine to mimic preconditioning in dogs. Circ. Res. 73: 1193-1201, 1993.
63. Yasuda, K., K. Raynor, H. Kong, C. Breder, J. Takeda, T. Reisine, and G. I. Bell. Cloning and function comparison of kappa and delta opioid receptors from mouse brain. Proc. Natl. Acad. Sci. USA 90: 6736-6740, 1993.
64. Ytrehus, K., E. Bugge, J. Starkopf, and A. K. Jonassen. Mechanisms of endogenous protection against infarction in the rat heart: from oxidative stress to signal transduction? (Abstract). J. Mol. Cell. Cardiol. 29: A14, 1997.
65. Ytrehus, K., Y. Liu, and J. M. Downey. Preconditioning protects ischemic rabbit heart by protein kinase C activation. Am. J. Physiol. 266 (Heart Circ. Physiol. 35): H1145-H1152, 1994.
66. Zimlichman, R., D. Gefel, H. Eliahou, Z. Matas, B. Rosen, S. Gass, C. Ela, Y. Eilam, Z. Vogel, and J. Barg. Expression of opioid receptors during heart ontogeny in normotensive and hypertensive rats. Circulation 93: 1020-1025, 1996.